Epco, Zanu, Ritux for R/R FL or MZL

Clinical trial NCT06563596 · RECRUITING

Trial details

NCT number: NCT06563596
Sponsor: Reid Merryman, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Lymphoma Non-Hodgkin Lymphoma Relapsed Lymphoma Refractory Lymphoma Marginal Zone Lymphoma

Start date: 2025-01-21
Primary completion: 2028-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.